Global Gastric Motility Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Gastric Motility Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.
Gastric Motility Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gastric Motility Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Gastritis and Reflux Esophagitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gastric Motility Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Gastric Motility Drugs key manufacturers include Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin and Sigma-Tau Group, etc. Johnson & Johnson, Sumitomo Dainippon, Sanofi are top 3 players and held % sales share in total in 2022.
Gastric Motility Drugs can be divided into Monotherapy and Poly Pill, etc. Monotherapy is the mainstream product in the market, accounting for % sales share globally in 2022.
Gastric Motility Drugs is widely used in various fields, such as Chronic Gastritis, Reflux Esophagitis, Functional Dyspepsia and Others, etc. Chronic Gastritis provides greatest supports to the Gastric Motility Drugs industry development. In 2022, global % sales of Gastric Motility Drugs went into Chronic Gastritis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gastric Motility Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Johnson & Johnson
Sumitomo Dainippon
Sanofi
Pfizer
Teva
GrupoFarma
Abbott
Kyowa Kirin
Sigma-Tau Group
Wilmington
Chengdu Kanghong Pharmaceutical Group Co.,Ltd
Lunan Pharmaceutical Group Corporation
Hansoh Pharmaceutical Group Company Limited
Shanghai Sine Pharmaceutical Laboratories Co., Ltd
Disha Pharmaceutical Group Co., Ltd
Xian Janssen Pharmaceutical Ltd
Segment by Type
Monotherapy
Poly Pill
Chronic Gastritis
Reflux Esophagitis
Functional Dyspepsia
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gastric Motility Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gastric Motility Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gastric Motility Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Gastric Motility Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gastric Motility Drugs introduction, etc. Gastric Motility Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Gastric Motility Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Gastric Motility Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gastric Motility Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chronic Gastritis and Reflux Esophagitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gastric Motility Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Gastric Motility Drugs key manufacturers include Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin and Sigma-Tau Group, etc. Johnson & Johnson, Sumitomo Dainippon, Sanofi are top 3 players and held % sales share in total in 2022.
Gastric Motility Drugs can be divided into Monotherapy and Poly Pill, etc. Monotherapy is the mainstream product in the market, accounting for % sales share globally in 2022.
Gastric Motility Drugs is widely used in various fields, such as Chronic Gastritis, Reflux Esophagitis, Functional Dyspepsia and Others, etc. Chronic Gastritis provides greatest supports to the Gastric Motility Drugs industry development. In 2022, global % sales of Gastric Motility Drugs went into Chronic Gastritis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gastric Motility Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Johnson & Johnson
Sumitomo Dainippon
Sanofi
Pfizer
Teva
GrupoFarma
Abbott
Kyowa Kirin
Sigma-Tau Group
Wilmington
Chengdu Kanghong Pharmaceutical Group Co.,Ltd
Lunan Pharmaceutical Group Corporation
Hansoh Pharmaceutical Group Company Limited
Shanghai Sine Pharmaceutical Laboratories Co., Ltd
Disha Pharmaceutical Group Co., Ltd
Xian Janssen Pharmaceutical Ltd
Segment by Type
Monotherapy
Poly Pill
Segment by Application
Chronic Gastritis
Reflux Esophagitis
Functional Dyspepsia
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gastric Motility Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gastric Motility Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gastric Motility Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Gastric Motility Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gastric Motility Drugs introduction, etc. Gastric Motility Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Gastric Motility Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices